The scientific community is increasingly certain that the success of the fight against the most aggressive tumors lies in attacking multiple fronts simultaneously to prevent the escape of tumor cells that enable disease progression.
The findings mark a breakthrough in a tumor type that has seen no significant therapeutic advances in two decades, improving progression-free survival from 10 to 14.6 months.
Collection
[
|
...
]